Tommi Vaskivuo
Chairman of the Board
Testi Technologies Oy
Estonia
Tommi Vaskivuo, MD PhD, is a specialist in clinical chemistry, assistant professor (docent), technology entrepreneur, and chairman of the board of Testi Technologies Oy, a Finnish company developing saliva-based detection technologies. He has over 20 years of international experience in clinical diagnostics, their use, and their development, with a strong focus on translating scientific advances into practical solutions.
Aiheet
Challenges and Opportunities in Developing Saliva-Based Consumer Tests
Quality in Laboratory Medicine
Direct-to-Consumer Testing
6.2.2026 13:30 - 14:00 | Hall 208
Saliva is a promising sample type for direct-to-consumer testing due to its non-invasive collection, but it also brings challenges in sample variability, and assay sensitivity. This presentation explores the development of novel saliva-based tests for alcohol and glucose detection. Key topics include biomarker selection, assay design, and early-stage verification of analytical performance. The talk highlights how scientific rigor, usability, and regulatory considerations can be integrated into consumer-oriented diagnostics. Real-world development experiences will be shared to illustrate the potential and limitations of saliva-based DTCT solutions.